Human medicines European public assessment report (EPAR): Emend, aprepitant, Vomiting,Postoperative Nausea and Vomiting,Cancer, Date of authorisation: 11/11/2003, Revision: 25, Status: Authorised

Case Medical Research ◽

10.31525/cmr-24afe47 ◽

2019 ◽

Author(s):

Keyword(s):

Postoperative Nausea ◽

Postoperative Nausea And Vomiting ◽

Nausea And Vomiting ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Emend, aprepitant, Vomiting,Postoperative Nausea and Vomiting,Cancer, Date of authorisation: 11/11/2003, Revision: 25, Status: Authorised

Case Medical Research ◽

10.31525/cmr-24ad82a ◽

2019 ◽

Author(s):

Keyword(s):

Postoperative Nausea ◽

Postoperative Nausea And Vomiting ◽

Nausea And Vomiting ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

The effect of smoking on postoperative nausea and vomiting

Anaesthesia ◽

10.1046/j.1365-2044.2000.01727-14.x ◽

2000 ◽

Vol 55 (10) ◽

pp. 1032-1032 ◽

Author(s):

R. Thomas

Keyword(s):

Postoperative Nausea ◽

Postoperative Nausea And Vomiting ◽

Nausea And Vomiting

Download Full-text

Use of reversal agents in day care procedures (with special reference to postoperative nausea and vomiting)

European Journal of Anaesthesiology ◽

10.1046/j.1365-2346.2001.018s23053.x ◽

2001 ◽

Vol 18 (Suppl. 23) ◽

pp. 53-59 ◽

Author(s):

T. Fuchs-Buder ◽

T. Mencke

Keyword(s):

Special Reference ◽

Postoperative Nausea ◽

Day Care ◽

Postoperative Nausea And Vomiting ◽

Nausea And Vomiting ◽

Reversal Agents

Download Full-text

Human medicines European public assessment report (EPAR): Fabrazyme, agalsidase beta, Fabry Disease, Date of authorisation: 03/08/2001, Revision: 26, Status: Authorised

Case Medical Research ◽

10.31525/cmr-19715f1 ◽

2019 ◽

Author(s):

Keyword(s):

Fabry Disease ◽

Agalsidase Beta ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Controloc Control, pantoprazole, Gastroesophageal Reflux, Date of authorisation: 11/06/2009, Revision: 11, Status: Authorised

Case Medical Research ◽

10.31525/cmr-193042d ◽

2019 ◽

Author(s):

Keyword(s):

Gastroesophageal Reflux ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Striascan, ioflupane (123i), Radionuclide Imaging,Dementia,Movement Disorders, Date of authorisation: 25/06/2019

Case Medical Research ◽

10.31525/cmr-193042a ◽

2019 ◽

Author(s):

Keyword(s):

Radionuclide Imaging ◽

Movement Disorders ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Dementia,Alzheimer Disease,Parkinson Disease, Date of authorisation: 11/12/2009, Revision: 10, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1930425 ◽

2019 ◽

Author(s):

Keyword(s):

Alzheimer Disease ◽

Parkinson Disease ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Ribavirin Mylan (previously Ribavirin Three Rivers), ribavirin, Hepatitis C, Chronic, Date of authorisation: 10/06/2010, Revision: 10, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1907582 ◽

2019 ◽

Author(s):

Keyword(s):

Hepatitis C ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Download Full-text

Human medicines European public assessment report (EPAR): LysaKare, arginine / lysine, Radiation Injuries, Date of authorisation: 25/07/2019, Status: Authorised

Case Medical Research ◽

10.31525/cmr-18ff4a5 ◽

2019 ◽

Author(s):

Keyword(s):

Radiation Injuries ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Irbesartan Zentiva (previously Irbesartan Winthrop), irbesartan, Hypertension, Date of authorisation: 19/01/2007, Revision: 21, Status: Authorised

Case Medical Research ◽

10.31525/cmr-134bca5 ◽

2019 ◽

Author(s):

Keyword(s):

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text